Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add filters

Database
Language
Document Type
Year range
1.
Respirol Case Rep ; 10(12): e01062, 2022 Dec.
Article in English | MEDLINE | ID: covidwho-2094242

ABSTRACT

Negative pressure pulmonary edema (NPPE) should be considered in the differential diagnosis from an episode of asphyxia, and even if NPPE is diagnosed, the possibility of COVID-19 should be kept in mind under coronavirus pandemic conditions.

2.
Commun Biol ; 5(1): 647, 2022 07 04.
Article in English | MEDLINE | ID: covidwho-1972668

ABSTRACT

The continuous emergence of microbial pathogens for which there are no effective antimicrobials threatens global health, necessitating novel antimicrobial approaches. Here, we present a targeted antimicrobial strategy that can be applied to various microbial pathogens. A photoimmuno-conjugate composed of an antibody against the target pathogen and a photoplastic phthalocyanine-derivative probe that generates photo-induced mechanical stress was developed based on photoimmuno-technology. This strategy, named as photoimmuno-antimicrobial strategy (PIAS), eliminates targeted pathogens, regardless of the target species or drug-resistance status. Specifically, PIAS acts on a broad range of microbes, including the bacterial pathogen Staphylococcus aureus, fungal pathogen Candida albicans, including their drug-resistant strains, and viral pathogen SARS-CoV-2, the causative agent of COVID-19. Furthermore, PIAS protects mice from fatal infections without damaging the non-targeted host microbiota and tissues. This study may contribute to the development of next-generation anti-infective therapies.


Subject(s)
Anti-Infective Agents , COVID-19 Drug Treatment , Animals , Anti-Bacterial Agents/pharmacology , Anti-Infective Agents/pharmacology , Bacteria , Mice , SARS-CoV-2
SELECTION OF CITATIONS
SEARCH DETAIL